{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:42:24Z","timestamp":1762674144056,"version":"3.44.0"},"reference-count":174,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780444637499"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-444-63749-9.00002-5","type":"book-chapter","created":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T16:03:41Z","timestamp":1475424221000},"page":"45-79","source":"Crossref","is-referenced-by-count":13,"title":["Natural Products as Lead Protein Kinase C Modulators for Cancer Therapy"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0006-291X(77)80013-2","article-title":"A proenzyme of cyclic nucleotide-independent protein kinase and its activation by calcium-dependent neutral protease from rat liver","volume":"77","author":"Takai","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib2","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/S0021-9258(17)41009-X","article-title":"Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum","volume":"252","author":"Takai","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib3","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1016\/S0021-9258(17)41010-6","article-title":"Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain","volume":"252","author":"Inoue","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/oxfordjournals.jbchem.a132557","article-title":"A role of membranes in the activation of a new multifunctional protein kinase system","volume":"86","author":"Takai","year":"1979","journal-title":"J. Biochem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/0006-291X(79)91197-5","article-title":"Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system","volume":"91","author":"Takai","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib6","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0021-9258(19)85886-6","article-title":"Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover","volume":"255","author":"Kishimoto","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.1411571","article-title":"Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C","volume":"258","author":"Nishizuka","year":"1992","journal-title":"Science"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib8","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1016\/S0021-9258(18)34459-4","article-title":"Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters","volume":"257","author":"Castagna","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0006-291X(86)90008-2","article-title":"Staurosporine, a potent inhibitor of phospholipid\/Ca++dependent protein kinase","volume":"135","author":"Tamaoki","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0006-291X(84)80213-2","article-title":"Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells","volume":"120","author":"Rodriguez-Pena","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib11","first-page":"461","article-title":"Happy birthday protein kinase C: past, present and future of a superfamily","volume":"55","author":"Battaini","year":"2007","journal-title":"Pharmacol. Res. Off. J. Ital. Pharmacol. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20130220","article-title":"Protein kinase C pharmacology: refining the toolbox","volume":"452","author":"Alyssa","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1568009043481579","article-title":"Protein kinase C isozymes as potential targets for anticancer therapy","volume":"4","author":"Hofmann","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib14","doi-asserted-by":"crossref","first-page":"40305","DOI":"10.1074\/jbc.M307065200","article-title":"Protein kinase M\u03b6 synthesis from a brain mRNA encoding an independent protein kinase C\u03b6 catalytic domain implications for the molecular mechanism of memory","volume":"278","author":"Hernandez","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2011.04.096","article-title":"A novel mouse PKC\u03b4 splice variant, PKC\u03b4IX, inhibits etoposide-induced apoptosis","volume":"410","author":"Kim","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/bi7019782","article-title":"Identification of a novel antiapoptotic human protein kinase C \u03b4 isoform, PKC\u03b4VIII in NT2 cells","volume":"47","author":"Jiang","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/bbrc.2000.2331","article-title":"cDNA cloning of an alternative splicing variant of protein kinase C \u03b4 (PKC \u03b4III), a new truncated form of PKC\u03b4, in rats","volume":"269","author":"Ueyama","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib18","first-page":"E395","article-title":"Protein kinase C: poised to signal","volume":"298","author":"Newton","year":"2010","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1073\/pnas.81.2.607","article-title":"Competitive inhibition by diacylglycerol of specific phorbol ester binding","volume":"81","author":"Sharkey","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib20","doi-asserted-by":"crossref","first-page":"14866","DOI":"10.1016\/S0021-9258(18)98554-6","article-title":"Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme","volume":"266","author":"Mochly-Rosen","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib21","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1038\/sj.onc.1204778","article-title":"Adaptor proteins in protein kinase C-mediated signal transduction","volume":"20","author":"Schechtman","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib22","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/cr0002801","article-title":"Structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions","volume":"101","author":"Newton","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1042\/bst0290860","article-title":"AGC protein kinase phosphorylation and protein kinase C","volume":"29","author":"Parker","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021626","article-title":"Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm","volume":"370","author":"Newton","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib25","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2741\/3385","article-title":"Protein kinase C isoforms: multi-functional regulators of cell life and death","volume":"14","author":"Reyland","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib26","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1016\/S0021-9258(18)33427-6","article-title":"Decrease in cytosolic calcium\/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells","volume":"257","author":"Kraft","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(95)90011-X","article-title":"Crystal structure of the Cys2 activator-binding domain of protein kinase C\u03b4 in complex with phorbol ester","volume":"81","author":"Zhang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib28","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1074\/jbc.M709943200","article-title":"Kinetic analysis of the interaction of the C1 domain of protein kinase C with lipid membranes by stopped-flow spectroscopy","volume":"283","author":"Dries","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1083\/jcb.145.4.713","article-title":"PKC\u03b5, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells","volume":"145","author":"Zeidman","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2008.07.006","article-title":"Exploitation of protein kinase C: a useful target for cancer therapy","volume":"35","author":"Ali","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib31","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/onc.2013.524","article-title":"Protein kinase C and cancer: what we know and what we do not","volume":"33","author":"Garg","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1137::AID-CNCR19>3.0.CO;2-7","article-title":"Differential induction of cell death in human glioma cell lines by sodium nitroprusside","volume":"82","author":"Blackburn","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib33","first-page":"4612","article-title":"Protein kinase C\u03b1 and protein kinase C\u03b4 play opposite roles in the proliferation and apoptosis of glioma cells","volume":"61","author":"Mandil","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib34","doi-asserted-by":"crossref","first-page":"33753","DOI":"10.1074\/jbc.M303313200","article-title":"Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway","volume":"278","author":"Tanaka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib35","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1016\/S0021-9258(18)53223-3","article-title":"Overexpression of protein kinase C-delta and-epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity","volume":"268","author":"Mischak","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib36","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1100\/tsw.2010.214","article-title":"Two faces of protein kinase C\u03b4: the contrasting roles of PKC\u03b4 in cell survival and cell death","volume":"10","author":"Basu","year":"2010","journal-title":"Sci. World J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib37","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1158\/0008-5472.CAN-05-0553","article-title":"Protein kinase C\u03b5 is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy","volume":"65","author":"Pan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib38","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1158\/0008-5472.CAN-07-1604","article-title":"Protein kinase C\u03b5 interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer","volume":"67","author":"Aziz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib39","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1158\/0008-5472.CAN-06-4037","article-title":"Protein kinase C\u03b5 is overexpressed in primary human non\u2013small cell lung cancers and functionally required for proliferation of non\u2013small cell lung cancer cells in a p21\/Cip1-dependent manner","volume":"67","author":"Bae","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib40","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1038\/sj.onc.1206795","article-title":"Protein kinase C\u025b interacts with Bax and promotes survival of human prostate cancer cells","volume":"22","author":"McJilton","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4161\/cc.10.2.14469","article-title":"Transgenic overexpression of PKC\u03b5 in the mouse prostate induces preneoplastic lesions","volume":"10","author":"Benavides","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/MCB.01294-08","article-title":"Protein kinase C\u03b6 represses the interleukin-6 promoter and impairs tumorigenesis in\u00a0vivo","volume":"29","author":"Galvez","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib43","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1073\/pnas.1221799110","article-title":"c-Myc phosphorylation by PKC\u03b6 represses prostate tumorigenesis","volume":"110","author":"Kim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib44","first-page":"1815","article-title":"Atypical protein kinase C \u03b6 as a target for chemosensitization of tumor cells","volume":"62","author":"Filomenko","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib45","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.1074\/jbc.M701613200","article-title":"Protein kinase C\u03b6 abrogates the proapoptotic function of Bax through phosphorylation","volume":"282","author":"Xin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib46","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1093\/emboj\/cdf407","article-title":"Role of \u03b6PKC in B-cell signaling and function","volume":"21","author":"Martin","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib47","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/j.1460-2075.1994.tb06578.x","article-title":"Zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in\u00a0vitro","volume":"13","author":"Diaz-Meco","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib48","first-page":"2338","article-title":"Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae","volume":"28","author":"Hecker","year":"1968","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-2952(84)90448-9","article-title":"Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands","volume":"33","author":"Blumberg","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib50","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1271\/bbb.120162","article-title":"Artificial analogs of naturally occurring tumor promoters as biochemical tools and therapeutic leads","volume":"76","author":"Nakagawa","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib51","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.M314082200","article-title":"The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A","volume":"279","author":"Gassel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib52","first-page":"2644","article-title":"Effects of structural changes on the tumor-promoting activity of phorbol myristate acetate on mouse skin","volume":"39","author":"Van Duuren","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib53","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjp.0705213","article-title":"Phorbol esters and neurotransmitter release: more than just protein kinase C?","volume":"138","author":"Silinsky","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib54","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1073\/pnas.83.12.4214","article-title":"Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs","volume":"83","author":"Wender","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib55","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1021\/bi970833a","article-title":"NMR structure of a protein kinase C-\u03b3 phorbol-binding domain and study of protein-lipid micelle interactions","volume":"36","author":"Xu","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib56","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/301621a0","article-title":"Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane","volume":"301","author":"Kraft","year":"1983","journal-title":"Nature"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/np50001a006","article-title":"Characterization of an irritant 4-deoxyphorbol diester from Euphorbia tirucalli","volume":"42","author":"Kinghorn","year":"1979","journal-title":"J. Nat. Prod."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/ja971270t","article-title":"Rational design, synthesis, and evaluation of a new type of PKC inhibitor","volume":"120","author":"Sodeoka","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/asia.200600185","article-title":"Identification of potent, selective protein kinase C inhibitors based on a phorbol skeleton","volume":"1","author":"Yamatsugu","year":"2006","journal-title":"Chem. Asian J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib60","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1073\/pnas.95.9.5357","article-title":"Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukaemia: preliminary studies on therapeutic efficacy and toxicity","volume":"95","author":"Han","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib61","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1172\/JCI109939","article-title":"Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukaemia","volume":"66","author":"Koeffler","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib62","first-page":"2512","article-title":"Administration of a phorbol ester to patients with hematological malignancies preliminary results from a phase I clinical trial of 12-O-Tetradecanoylphorbol-13-acetate","volume":"8","author":"Strair","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib63","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1073\/pnas.76.3.1293","article-title":"Induction of terminal differentiation in human promyelocytic leukaemia cells by tumor-promoting agents","volume":"76","author":"Huberman","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G","article-title":"Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters","volume":"28","author":"Kazanietz","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib65","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/AEM.67.10.4531-4537.2001","article-title":"Evidence for the biosynthesis of bryostatins by the bacterial symbiont \u2018Candidatus Endobugula sertula\u2019 of the bryozoan Bugula neritina","volume":"67","author":"Davidson","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib66","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1021\/ja00388a092","article-title":"Isolation and structure of bryostatin 1","volume":"104","author":"Pettit","year":"1982","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib67","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/227962a0","article-title":"Antineoplastic components of marine animals","volume":"227","author":"Pettit","year":"1970","journal-title":"Nature"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib68","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.V75.6.1319.1319","article-title":"Bryostatin 1, a unique biologic response modifier: anti-leukemic","volume":"75","author":"Jones","year":"1990","journal-title":"Blood"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib69","first-page":"101","article-title":"Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in\u00a0vitro versus in\u00a0vivo activity","volume":"52","author":"Hornung","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib70","first-page":"682","article-title":"Successful treatment of murine melanoma with bryostatin 1","volume":"51","author":"Schuchter","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10637-006-6452-1","article-title":"A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma","volume":"24","author":"Ajani","year":"2006","journal-title":"Invest. New Drugs"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib72","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/1078-0432.CCR-06-1419","article-title":"Phase I study of bryostatin 1 and gemcitabine","volume":"12","author":"El-Rayes","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/13880209.2013.804100","article-title":"Marine natural products: bryostatins in preclinical and clinical studies","volume":"52","author":"Koll\u00e1r","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib74","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1073\/pnas.95.12.6624","article-title":"The design, computer modeling, solution structure, and biological evaluation of synthetic analogs of bryostatin 1","volume":"95","author":"Wender","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib75","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/ja110198y","article-title":"Total synthesis of bryostatin 1","volume":"133","author":"Keck","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib76","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1021\/ja990860j","article-title":"Total synthesis of bryostatin 2","volume":"121","author":"Evans","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib77","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/1521-3773(20000703)39:13<2290::AID-ANIE2290>3.0.CO;2-6","article-title":"Total synthesis of bryostatin 3","volume":"39","author":"Ohmori","year":"2000","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib78","first-page":"744","volume":"6","author":"Zhang","year":"2011","journal-title":"Total Synth. Bryostatin"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib79","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1021\/ja203034k","article-title":"Total synthesis of bryostatin 9","volume":"133","author":"Wender","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib80","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature07543","article-title":"Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches","volume":"456","author":"Trost","year":"2008","journal-title":"Nature"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1039\/b009211h","article-title":"The chemistry and biology of the bryostatin antitumour macrolides","volume":"19","author":"Hale","year":"2002","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib82","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1073\/pnas.85.19.7197","article-title":"Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C","volume":"85","author":"Wender","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/ar700155p","article-title":"Function-oriented synthesis, step economy, and drug design","volume":"41","author":"Wender","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib84","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1016\/S0040-4039(00)01100-X","article-title":"Synthesis and biological evaluation of a new class of bryostatin analogues: the role of the C20 substituent in protein kinase C binding","volume":"41","author":"Wender","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib85","doi-asserted-by":"crossref","first-page":"13648","DOI":"10.1021\/ja027509+","article-title":"The practical synthesis of a novel and highly potent analogue of bryostatin","volume":"124","author":"Wender","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib86","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/ol0272390","article-title":"A concise, selective synthesis of the polyketide spacer domain of a potent bryostatin analogue","volume":"5","author":"Wender","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib87","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/ol0504650","article-title":"Role of the A-ring of bryostatin analogues in PKC binding: synthesis and initial biological evaluation of new A-ring-modified bryologs","volume":"7","author":"Wender","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib88","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/ol060457z","article-title":"Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin","volume":"8","author":"Wender","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib89","doi-asserted-by":"crossref","DOI":"10.1021\/acs.accounts.5b00004","article-title":"Function through synthesis-informed design","volume":"48","author":"Wender","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib90","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1021\/ol0620904","article-title":"Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogs","volume":"8","author":"Wender","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib91","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/ol0501931","article-title":"Identification of a tunable site in bryostatin analogs: C20 bryologs through late stage diversification","volume":"7","author":"Wender","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib92","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/ol801235h","article-title":"The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinity","volume":"10","author":"Wender","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib93","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/ol900585t","article-title":"The bryostatin 1 A-ring acetate is not the critical determinant for antagonism of phorbol ester-induced biological responses","volume":"11","author":"Keck","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib94","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1021\/ja8022169","article-title":"Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function","volume":"130","author":"Keck","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib95","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1021\/ja507825s","article-title":"Synthesis of seco-B-ring bryostatin analogue WN-1 via CC bond-forming hydrogenation: critical contribution of the B-ring in determining bryostatin-like and phorbol 12-myristate 13-acetate-like properties","volume":"136","author":"Andrews","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2006.00001.x","article-title":"Bryostatin-1: pharmacology and therapeutic potential as a CNS drug","volume":"12","author":"Sun","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7164\/antibiotics.30.275","article-title":"A new alkaloid AM-2282 of Streptomyces origin taxonomy, fermentation, isolation and preliminary characterization","volume":"30","author":"Omura","year":"1977","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib98","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1099\/00207713-52-5-1815","article-title":"Description of Lentzea flaviverrucosa sp. nov. and transfer of the type strain of Saccharothrix aerocolonigenes subsp. staurosporea to Lentzea albida","volume":"52","author":"Xie","year":"2002","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib99","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1039\/B601930G","article-title":"Indolocarbazole natural products: occurrence, biosynthesis, and biological activity","volume":"23","author":"Sanchez","year":"2006","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0197-0186(93)90040-C","article-title":"Characterization of [3H]staurosporine binding in protein kinase C-II purified from rat brain","volume":"22","author":"Miyazaki","year":"1993","journal-title":"Neurochem. Int."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib101","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0960-894X(94)80004-9","article-title":"Inhibitory activity and selectivity of staurosporine derivatives towards protein kinase C","volume":"4","author":"Caravatti","year":"1994","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib102","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0026-895X(25)10590-7","article-title":"Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue","volume":"45","author":"Seynaeve","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib103","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0091270005274549","article-title":"Review of UCN-01 development: a lesson in the importance of clinical pharmacology","volume":"45","author":"Fuse","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib104","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.2910430519","article-title":"A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in\u00a0vitro anti-proliferative as well as in\u00a0vivo anti-tumor activity","volume":"43","author":"Meyer","year":"1989","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib105","unstructured":"ClinicalTrials.gov. at http:\/\/clinicaltrials.gov."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.thj.6200165","article-title":"A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C","volume":"3","author":"Virchis","year":"2002","journal-title":"Hematol. J."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood-2004-03-0891","article-title":"Patients with acute myeloid leukaemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412","volume":"105","author":"Stone","year":"2005","journal-title":"Blood"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib108","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1040-8428(00)00058-5","article-title":"Staurosporine analogues \u2014 pharmacological toys or useful antitumour agents?","volume":"34","author":"Gescher","year":"2000","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib109","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1016\/S0960-894X(03)00792-3","article-title":"Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides","volume":"13","author":"Sanchez-Martinez","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-5793(96)01510-4","article-title":"The protein kinase C inhibitors Ro318220 and GF109203X are equally potent inhibitors of MAPKAP kinase-1\u03b2 (Rsk-2) and p70S6 kinase","volume":"402","author":"Alessi","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib111","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0960-894X(03)00286-5","article-title":"Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKC\u03b2","volume":"13","author":"Faul","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib112","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/jo971980h","article-title":"Macrocyclic Bisindolylmaleimides:synthesis by inter- and intramolecular alkylation","volume":"63","author":"Faul","year":"1998","journal-title":"J. Org. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib113","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1517\/14656560903401620","article-title":"Ruboxistaurin: PKC-\u03b2 inhibition for complications of diabetes","volume":"10","author":"Danis","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/0015587X.1991.9715809","article-title":"Plants and wart cures in England from the seventeenth to the nineteenth century: some examples","volume":"102","author":"Drury","year":"1991","journal-title":"Folklore"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib115","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0031-9422(00)81076-6","article-title":"Biologically active diterpene esters from Euphorbia peplus","volume":"24","author":"Rizk","year":"1985","journal-title":"Phytochemistry"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2000-8568","article-title":"Diterpenoids from Euphorbia peplus","volume":"66","author":"Hohmann","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib117","first-page":"633","article-title":"The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers","volume":"164","author":"Ramsay","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib118","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2306\/scienceasia1513-1874.1983.09.081","article-title":"3-O-angeloylingenol, the toxic and skin irritant factor from latex of Euphorbia antiquorum L. (Euphorbiaceae) and from a derived Thai purgative and anthelimintic (vermifuge) drug","volume":"9","author":"Adolf","year":"1983","journal-title":"J. Sci. Soc. Thail."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib119","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1515\/znb-1984-0525","article-title":"On the active principles of the Euphorbiaceae .9. Ingenane type diterpene esters from 5 Euphorbia species","volume":"39","author":"Gotta","year":"1984","journal-title":"Z. Naturforsch. Sect. B-A J. Chem. Sci."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s004320050146","article-title":"Dietary cancer risk conditional cancerogens in produce of livestock fed on species of spurge (Euphorbiaceae)","volume":"124","author":"Zayed","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib121","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1535-7163.1651.3.12","article-title":"Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor\u2013related apoptosis-inducing ligand\u2013induced apoptosis in melanoma cells","volume":"3","author":"Gillespie","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib122","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumor activity of 3-Ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"Ogbourne","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib123","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.bjc.6604642","article-title":"Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells","volume":"99","author":"Benhadji","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib124","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1535-7163.MCT-07-2060","article-title":"Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells","volume":"7","author":"Serova","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib125","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","article-title":"Characterization of the interaction of ingenol 3-angelate with protein kinase C","volume":"64","author":"Kedei","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib126","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bmcl.2013.11.073","article-title":"Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer","volume":"24","author":"Grue-S\u00f8rensen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib127","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1016\/j.bmcl.2013.08.038","article-title":"Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer","volume":"23","author":"Liang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib128","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1241606","article-title":"14-Step synthesis of (+)-Ingenol from (+)-3-Carene","volume":"341","author":"J\u00f8rgensen","year":"2013","journal-title":"Science"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"Rosen","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib130","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1074\/jbc.M109.041962","article-title":"Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase C?","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib131","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-2001-18843","article-title":"Differential activation by daphnetoxin and mezerein of PKC-Isotypes \u03b1, \u03b2I, \u03b4 and \u03b6","volume":"67","author":"Saraiva","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib132","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1016\/S0040-4039(00)89459-9","article-title":"The structure of mezerein, a major toxic principle of Daphne mezereum L","volume":"11","author":"Ronl\u00e1n","year":"1970","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib133","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1021\/ja00707a058","article-title":"Isolation and structure of daphnetoxin, the poisonous principle of Daphne species","volume":"92","author":"Stout","year":"1970","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib134","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.1114315","article-title":"Mezerein: antileukemic principle isolated from Daphne mezereum L","volume":"187","author":"Kupchan","year":"1975","journal-title":"Science"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib135","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.286421","article-title":"Induction of differentiation in human promyelocytic leukaemia cells by tumor promoters","volume":"204","author":"Rovera","year":"1979","journal-title":"Science"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib136","first-page":"4791","article-title":"Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3\u2032: 5\u2032-monophosphate, and induction of mouse skin tumors in\u00a0vivo","volume":"39","author":"Mufson","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib137","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jnci\/81.9.676","article-title":"Further characterization of skin tumor promotion and progession by mezerein in SENCAR mice","volume":"81","author":"Ewing","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"year":"1985","series-title":"Screening Data Summary Compound NSC 239072","author":"Bethesda","key":"10.1016\/B978-0-444-63749-9.00002-5_bib138"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib139","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jps.3030310201","article-title":"Salvia carnosa (dougl.). I\u2014A phytochemical study","volume":"31","author":"White","year":"1942","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/jf950374p","article-title":"Antioxidant activity of a Rosemary extract and its constituents, carnosic acid, carnosol, and Rosmarinic acid, in bulk oil and oil-in-water emulsion","volume":"44","author":"Frankel","year":"1996","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2011.02.005","article-title":"Carnosol: a promising anti-cancer and anti-inflammatory agent","volume":"305","author":"Johnson","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib142","first-page":"2522","article-title":"Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein\/p300-dependent and -independent mechanisms","volume":"62","author":"Subbaramaiah","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib143","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1039\/c4fo00023d","article-title":"Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines","volume":"5","author":"Vergara","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib144","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.phytochem.2006.02.018","article-title":"Insect-antifeedant and antibacterial activity of diterpenoids from species of Plectranthus","volume":"67","author":"Wellsow","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1055\/s-2002-34407","article-title":"Effect of abietane diterpenes from Plectranthus grandidentatus on the growth of human cancer cell lines","volume":"68","author":"Marques","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib146","doi-asserted-by":"crossref","first-page":"P1L152","DOI":"10.1055\/s-0034-1394809","article-title":"Abietane diterpenes from Plectranthus madagascariensis: a cytotoxicity screening","volume":"80","author":"Matias","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib147","first-page":"4","article-title":"Leaf-gland pigments: coleons U, V, W, 14-O-Formyl-coleon-V, and two Royleanones from Pleetranthus myrianthus BRIQ.; cis- and trans-a\/B-6,7-dioxoroyleanon","volume":"13","author":"Miyase","year":"1977","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib148","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1021\/np400172k","article-title":"Antiproliferative activity of abietane diterpenoids against human tumor cells","volume":"76","author":"Burmistrova","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib149","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bmc.2003.10.006","article-title":"Effect of abietane diterpenes from Plectranthus grandidentatus on T- and B-lymphocyte proliferation","volume":"12","author":"Cerqueira","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bcp.2009.04.026","article-title":"Selective activation of protein kinase C-delta and -epsilon by 6,11,12,14-tetrahydroxy-abieta-5,8,11,13-tetraene-7-one (coleon U)","volume":"78","author":"Coutinho","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib151","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/np0102049","article-title":"Abietane diterpenoids from Coleus xanthanthus","volume":"65","author":"Mei","year":"2002","journal-title":"J. Nat. Prod."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib152","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1021\/jf302179c","article-title":"Degradation study of carnosic acid, carnosol, Rosmarinic acid, and Rosemary extract (Rosmarinus officinalis L.) assessed using HPLC","volume":"60","author":"Zhang","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib153","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/carcin\/14.5.857","article-title":"Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells","volume":"14","author":"Liu","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib154","first-page":"149","volume":"595","author":"Surh","year":"2007"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjp.0706970","article-title":"Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions","volume":"150","author":"Mahmmoud","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib156","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.bmc.2009.12.075","article-title":"Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C","volume":"18","author":"Majhi","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib157","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1016\/j.bmc.2011.09.011","article-title":"Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C","volume":"19","author":"Das","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib158","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","article-title":"Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins","volume":"269","author":"Kunnumakkara","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib159","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-5793(94)80232-7","article-title":"Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase","volume":"341","author":"Reddy","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib160","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4155\/tde.11.97","article-title":"Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, NF-\u03baB and HDAC in breast cancer","volume":"2","author":"Roy","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib161","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10408690490424702","article-title":"Biological properties of curcumin-cellular and molecular mechanisms of action","volume":"44","author":"Joe","year":"2004","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib162","first-page":"2783","article-title":"Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies","volume":"24","author":"Aggarwal","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib163","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/iub.47","article-title":"Resveratrol: one molecule, many targets","volume":"60","author":"Pirola","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib164","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/abbi.1999.1507","article-title":"The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C \u03b1 activity","volume":"372","author":"Garc\u00eda-Garc\u00eda","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib165","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1021\/bi990875u","article-title":"Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism","volume":"38","author":"Stewart","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib166","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(00)00450-0","article-title":"Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation","volume":"60","author":"Stewart","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib167","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0006-2952(01)00788-2","article-title":"Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism","volume":"62","author":"Atten","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib168","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/sj.onc.1207307","article-title":"Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC \u03b4 signal transduction","volume":"23","author":"Woo","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib169","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0006-2952(89)90309-2","article-title":"Protein kinase C inhibition by plant flavonoids: kinetic mechanisms and structure-activity relationships","volume":"38","author":"Ferriola","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/01635589709514572","article-title":"Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells","volume":"28","author":"Lee","year":"1997","journal-title":"Nutr. Cancer"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib171","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/carcin\/bgn162","article-title":"Quercetin inhibition of tumor invasion via suppressing PKC\u03b4\/ERK\/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells","volume":"29","author":"Lin","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib172","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00280-003-0702-0","article-title":"Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway","volume":"53","author":"Zhang","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib173","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00280-004-0863-5","article-title":"Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-\u03b1 and translocating PKC-\u03b4","volume":"55","author":"Zhang","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-444-63749-9.00002-5_bib174","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00280-011-1596-x","article-title":"Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells","volume":"68","author":"Staedler","year":"2011","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Studies in Natural Products Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780444637499000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780444637499000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:57:04Z","timestamp":1757541424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444637499000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780444637499"],"references-count":174,"URL":"https:\/\/doi.org\/10.1016\/b978-0-444-63749-9.00002-5","relation":{},"ISSN":["1572-5995"],"issn-type":[{"type":"print","value":"1572-5995"}],"subject":[],"published":{"date-parts":[[2016]]}}}